Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection

SC Gordon, S Geyik, O Clermont, CL O'Brien, S Huang, C Abayasekara, M Rajesh, K Kennedy, P Collignon, P Pavli, Christophe RODRIGUEZ, BD Johnston, JR Johnson, JW Decousser, E Denamur,

mSphere 31/05/2017;2(3) : pii: e00168-17 10.1128/mSphere.00168-17

Contribution of Ultra Deep Sequencing in the Clinical Diagnosis of a New Fungal Pathogen Species: Basidiobolus meristosporus.

E Sitterle, Christophe RODRIGUEZ, R Mounier, Julien CALDERARO, F Foulet, M Develoux, Jean-Michel PAWLOTSKY, F Botterel,

Front Microbiol. 07/03/2017;8 : 334 10.3389/fmicb.2017.00334.

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

C Soulie, L Assoumou, Mélanie MERCIER-DARTY, Christophe RODRIGUEZ, F Donati, S Sayon, G Peytavin, MA Valantin, F Caby, L Schneider, A Canestri, D Costagliola, C Katlama, V Calvez, AG Marcelin,

J Antimicrob Chemother. 01/12/2015;70(12) : 3339-3344 10.1093/jac/dkv280 22/09/2015

Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.

A Wolfromm, Christophe RODRIGUEZ, M Michel, A Habibi, V Audard, E Benayoun, Olivier ROGIER, Dominique CHALLINE, O Chosidow, JD Lelievre, X Chevalier, F Le Bras, C Pautas, M Imbert, Jean-Michel PAWLOTSKY, O Wagner-Ballon,

Br J Haematol. 01/07/2015;170(2) : 192-199 10.1111/bjh.13421 28/04/2015

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.

C Charpentier, GQ Lee, Christophe RODRIGUEZ, B Visseaux, A Storto, C Fagard, JM Molina, C Katlama, Y Yazdanpanah, PR Harrigan, D Descamps,

J Antimicrob Chemother 01/07/2015;70(7) : 2090-2096 10.1093/jac/dkv048. 08/03/2015

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.

Christophe RODRIGUEZ, C Soulie, AG Marcelin, V Calvez, D Descamps, C Charpentier, P Flandre, P Recordon-Pinson, P Bellecave, Jean-Michel PAWLOTSKY, B Masquelier,

PLoS One. 11/06/2015;10(6) : e0127816 10.1371/journal.pone.0127816.

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.

E Todesco, Christophe RODRIGUEZ, L Morand-Joubert, Mélanie MERCIER-DARTY, N Desire, M Wirden, PM Girard, C Katlama, V Calvez, AG Marcelin,

J antimicrob Chemother. 01/05/2015;70(5) : 1503-1506 10.1093/jac/dku557. 21/01/2015

Reply: To PMID 23505208.

Christophe RODRIGUEZ, Stephane CHEVALIEZ, Jean-Michel PAWLOTSKY,

Hepatology 01/03/2014;59(3) : 1212-1213 10.1002/hep.26646. 13/01/2014

Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention.

J Hayer, Christophe RODRIGUEZ, G Germanidis, G Deleage, F Zoulim, Jean-Michel PAWLOTSKY, C Combet,

J Virol. 01/01/2014;88(1) : 574-582 10.1128/JVI.03000-13 30/10/2013

Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing.

Christophe RODRIGUEZ, Stephane CHEVALIEZ, P Bensadoun, Jean-Michel PAWLOTSKY,

Hepatology 01/09/2013;58(3) : 890-901 10.1002/hep.26383 30/07/2013